Related references
Note: Only part of the references are listed.GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo
Caroline Pabst et al.
BLOOD (2016)
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Rachel E. Rau et al.
BLOOD (2016)
Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
Tzu-Chieh Ho et al.
BLOOD (2016)
MLL-AF9-and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C
Nan Zhu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
Sheng Li et al.
NATURE MEDICINE (2016)
G Protein-Coupled Receptor Signaling in Stem Cells and Cancer
Jennifer R. Lynch et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
Alan H. Shih et al.
CANCER CELL (2015)
A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
Yoshikane Kikushige et al.
CELL STEM CELL (2015)
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
Helena Agerstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia
Manja Wobus et al.
ONCOTARGET (2015)
Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia
Carol O'Hear et al.
HAEMATOLOGICA (2015)
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia
Simon Z. He et al.
LEUKEMIA & LYMPHOMA (2015)
Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer
Zheng He et al.
ONCOLOGY LETTERS (2015)
International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors
Joerg Hamann et al.
PHARMACOLOGICAL REVIEWS (2015)
The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells
Chiharu I. Kobayashi et al.
BLOOD (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
Novel insights into G protein and G protein-coupled receptor signaling in cancer
Morgan O'Hayre et al.
CURRENT OPINION IN CELL BIOLOGY (2014)
Leukemia surfaceome analysis reveals new disease-associated features
Paulina Mirkowska et al.
BLOOD (2013)
Lysophosphatidylethanolamine utilizes LPA1 and CD97 in MDA-MB-231 breast cancer cells
Soo-Jin Park et al.
CELLULAR SIGNALLING (2013)
Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia
Mikkael A. Sekeres et al.
HAEMATOLOGICA (2013)
A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers
Francesco Bonardi et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model
Y. Ward et al.
ONCOGENE (2013)
Overexpression of CD97 Confers an Invasive Phenotype in Glioblastoma Cells and Is Associated with Decreased Survival of Glioblastoma Patients
Michael Safaee et al.
PLOS ONE (2013)
MEK/ERK Dependent Activation of STAT1 Mediates Dasatinib-Induced Differentiation of Acute Myeloid Leukemia
Yanfen Fang et al.
PLOS ONE (2013)
Klf5 controls bone marrow homing of stem cells and progenitors through Rab5-mediated β1/β2-integrin trafficking
E. Taniguchi Ishikawa et al.
NATURE COMMUNICATIONS (2013)
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS
Laura Barreyro et al.
BLOOD (2012)
The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
William J. Harris et al.
CANCER CELL (2012)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
Immunohistochemical Expression and Prognostic Value of CD97 and Its Ligand CD55 in Primary Gallbladder Carcinoma
Jinsheng Wu et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Thy-1 (CD90) Is an Interacting Partner for CD97 on Activated Endothelial Cells
Elke Wandel et al.
JOURNAL OF IMMUNOLOGY (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Clonal Architecture of Secondary Acute Myeloid Leukemia
Matthew J. Walter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
Jay P. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Invasion and Metastasis Promotion Role of CD97 Small Isoform in Gastric Carcinoma
Daren Liu et al.
PLOS ONE (2012)
Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
Max Jan et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
mTOR Signaling
Mathieu Laplante et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells
Yvona Ward et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
G protein-coupled receptors: novel targets for drug discovery in cancer
Rosamaria Lappano et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells
R. Majeti
ONCOGENE (2011)
TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
Yoshikane Kikushige et al.
CELL STEM CELL (2010)
The molecular signature of oncofusion proteins in acute myeloid leukemia
Joost H. A. Martens et al.
FEBS LETTERS (2010)
microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia
Yoon-Chi Han et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells
Yoriko Saito et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
Ravindra Majeti et al.
CELL (2009)
Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor α Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells
Liqing Jin et al.
CELL STEM CELL (2009)
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
Roel G. W. Verhaak et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
Yifang Hu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Jing Chen et al.
NUCLEIC ACIDS RESEARCH (2009)
Homing of Hematopoietic Cells to the Bone Marrow
Rushdia Z. Yusuf et al.
Jove-Journal of Visualized Experiments (2009)
An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
Klaus H. Metzeler et al.
BLOOD (2008)
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
Michael H. Tomasson et al.
BLOOD (2008)
CD97 is differentially expressed on murine hematopoietic stem- and progenitor-cells
Melissa van Pel et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Analysis of CD97 Expression and Manipulation: Antibody Treatment but Not Gene Targeting Curtails Granulocyte Migration
Henrike Veninga et al.
JOURNAL OF IMMUNOLOGY (2008)
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region
Fumihiko Ishikawa et al.
NATURE BIOTECHNOLOGY (2007)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Michele Milella et al.
BLOOD (2007)
Improved antibacterial host defense and altered peripheral granulocyte homeostasis in mice lacking the adhesion class G protein receptor CD97
Tao Wang et al.
INFECTION AND IMMUNITY (2007)
CD97 overexpression in tumor cells at the invasion front in colorectal cancer (CC) is independently regulated of the canonical Wnt pathway
Mania Wobus et al.
MOLECULAR CARCINOGENESIS (2006)
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Tim C. P. Somervaille et al.
CANCER CELL (2006)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis
Ming Yan et al.
NATURE MEDICINE (2006)
NF-κB and the regulation of hematopoiesis
V Bottero et al.
CELL DEATH AND DIFFERENTIATION (2006)
Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells
K Ito et al.
NATURE MEDICINE (2006)
Eradication of leukemia stem cells as a new goal of therapy in leukemia
F Ravandi et al.
CLINICAL CANCER RESEARCH (2006)
Stem cell research - Paths to cancer therapies and regenerative medicine
I Weissman
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
T Wang et al.
BLOOD (2005)
Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells
MJ Kwakkenbos et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans
M Stacey et al.
BLOOD (2003)
Downmodulation of ERK activity inhibits the proliferation and induces the apoptosis of primary acute myelogenous leukemia blasts
P Lunghi et al.
LEUKEMIA (2003)
Tissue distribution of the human CD97 EGF-TM7 receptor
LH Jaspars et al.
TISSUE ANTIGENS (2001)
Share Paper
